- Home
- Clinical Care
- Hair shedding or hair loss? What your hairbrush can and can’t tell you
Hair shedding or hair loss? What your hairbrush can and can’t tell you
Understanding hair shedding
Finding more hair in the shower or on a brush can be unsettling. But the number of strands you notice on one day cannot, by itself, tell you why your hair looks or feels different.
Hair naturally cycles through growth, rest and shedding. A change can reflect temporary excessive shedding, gradual thinning, breakage, or more than one process at once. Understanding the pattern is a useful first step.
When shedding increases
The American Academy of Dermatology says people commonly shed around 50 to 100 hairs a day. A temporary increase, called telogen effluvium, can appear months after a significant stressor such as an illness with fever, surgery or childbirth. Shedding may settle as the body readjusts, although the timing varies and persistent stressors can prolong it.
That does not mean every increase in shedding has the same explanation. Changes in a parting, a receding hairline or a patch of hair loss deserve their own assessment.
What a dermatologist looks for
A dermatologist may ask when the change began, whether it is diffuse or patchy, and about recent illness, medicines, hairstyles and family history. Examination of the scalp and hair can help distinguish causes; further tests are sometimes appropriate. A person can have both excessive shedding and another form of hair loss.
Seek professional advice if hair loss is sudden or patchy, the scalp is painful or inflamed, or the change persists or worries you. Do not stop a prescribed medicine without discussing it with the clinician who prescribed it.
Care while you investigate
Gentle handling and avoiding hairstyles that pull tightly on the hair can reduce avoidable damage. Supplements and products marketed for hair growth are not a substitute for finding the cause. A clinician can help decide what, if any, treatment is appropriate.
Source: American Academy of Dermatology: Do you have hair loss or hair shedding?
Photo: Oleskandra Biliak / Pexels. Illustrative photograph; not a person described in this article.
Clinical Care
View moreWhen someone has an infection, choosing the right treatment can depend on more than identifying symptoms. A laboratory test can help clinicians find the cause and, in some circumstances, determine which medicines are likely to work. On 16 November, the World Health Organization published an essential package of diagnostic tests for bacterial and fungal infections and antimicrobial resistance. It sets out a prioritized range of tests for different levels of care, from primary care to referral hospitals. The package includes rapid tests, microscopy, culture, serology and molecular methods. Some tests help identify an organism; antimicrobial susceptibility testing can help show whether a bacterium or fungus is likely to respond to particular medicines. Which test is appropriate depends on the patient, the suspected infection and the resources available. Testing also has limits. Results must be interpreted alongside the clinical picture, and not every infection requires the same test. For a seriously ill patient, a clinician may need to start treatment before results are available and adjust it later when more information arrives. WHO says access to reliable diagnostics remains uneven, particularly in low- and middle-income countries. Its package is intended to help health systems plan services and improve access to timely, quality-assured testing. During World AMR Awareness Week, the message is straightforward: better diagnosis can support better treatment decisions, while helping health systems track drug resistance. Patients should follow their clinician’s advice and ask what a test result means for their care. Source: World Health Organization, 16 November 2026.
Taking blood pressure at home: small steps that make readings more useful
Bone density and fracture risk: when to ask about a DXA scan
Diabetes and kidney health: the checks that can find trouble early
Some mornings, tiredness has an obvious explanation: a late night, a stressful week, or a child who kept waking up. But when exhaustion continues even after you have tried to rest, it can be difficult to know whether to wait it out or ask for help. Fatigue is a symptom, not a diagnosis. The most useful question is often: what else has changed, and how long has this been going on? Why you might feel tired Not getting enough sleep is one possible explanation, but it is far from the only one. Stress, low mood, pregnancy, menopause, recent illness and some medicines can all contribute. Persistent fatigue can also occur with conditions such as iron deficiency anaemia, diabetes, thyroid disorders or sleep apnoea. Other symptoms can provide clues. Someone with sleep apnoea might snore loudly or wake up gasping. A person with anaemia may also notice breathlessness or palpitations. These combinations can help a clinician decide what to investigate, but they cannot confirm a diagnosis on their own. When should you see a clinician? Make an appointment if you have been tired for a few weeks without a clear reason, if fatigue is affecting daily life, or if it comes with changes such as unexplained weight loss, mood changes or interrupted breathing during sleep. Before the appointment, note when the fatigue started, how you sleep, any other symptoms and any medicines or supplements you take. Depending on your history and examination, a clinician may suggest blood tests or further assessment. Seek emergency care for severe symptoms such as chest pain, severe difficulty breathing, fainting or new confusion. The takeaway Rest and a consistent sleep routine can help some people, but persistent fatigue deserves attention. You do not need to find the answer on your own before asking for help. Source: NHS: Tiredness and fatigue. Illustrative photograph: Ron Lach / Pexels.
Hair shedding or hair loss? What your hairbrush can and can’t tell you
For a small group with rectal cancer, immunotherapy changes the treatment conversation
After the smoke clears, wildfire survivors may still need lung-health follow-up
GRAYMEDY RESEARCH ANALYSIS · November 8, 2026 Before someone can weigh the benefits and burdens of research participation, they need a meaningful opportunity to consider it. A newly published national survey of U.S. women places that opportunity under scrutiny. An invitation gap Doruntina Fida, Therese A. Rajasekera, Primavera A. Spagnolo and colleagues surveyed 5,301 U.S. women aged 18–70. The peer-reviewed accepted paper appeared in Scientific Reports on November 7, 2026. The authors reported that 23% expressed definite willingness to participate and 60% answered maybe, while 11% said they had been invited and 7% had enrolled. Among respondents reporting race, the sample was predominantly White. Adjusted analyses associated lower willingness with being Black rather than White, while higher education and multimorbidity were associated with greater willingness. Respondents’ preferred information, motivations and perceived barriers also differed. These are associations within the surveyed population, rather than explanations of individual choices. Interest is not consent An expression of interest in a survey does not tell researchers whether someone would join a particular trial. A real decision depends on the intervention, uncertainty, visits, travel, childcare, costs and other personal circumstances. The maybe response is especially important: it represents a question requiring discussion rather than a commitment waiting to be activated. Graymedy’s reading is that the invitation gap deserves attention without turning willingness into a recruitment target that overrides autonomy. Improving access means giving eligible people understandable choices and enough room to decline. It does not mean assuming that everyone who is interested in research should enrol. What the design cannot resolve This was a cross-sectional online survey, not an experiment testing an invitation programme. Self-reported experience is subject to recall, and the people answering an online survey may differ from women who did not participate. The results therefore cannot establish a national causal explanation for underrepresentation. Race should not be read as a biological explanation for willingness. The study considers social and structural conditions alongside healthcare access, socioeconomic circumstances and health. A group-level result also cannot tell a clinician what an individual woman wants or why she might decline. Asking and listening remain essential. Turning a finding into a care question The authors call for evaluation of culturally responsive engagement, trust-building and approaches that reduce burden. Those are strategies to test, rather than interventions proven effective by this survey. A useful next study would measure whether changes improve informed opportunities and representation while preserving the quality of consent. At a service level, one possible audit would track eligible patients, invitations offered, invitations understood and participation decisions. Recording reasons for not being invited could reveal a different problem from recording reasons for declining. Such an audit would also need to protect privacy and avoid making research participation feel like a condition of good care. The central message is modest but consequential: low enrolment cannot automatically be equated with low interest. Research teams need to understand the route between a person’s willingness to hear more and the practical opportunity to make an informed choice. Sources and publication dates Fida et al., Scientific Reports, November 7, 2026; accepted article version Independent editorial analysis of published research; no interview or endorsement is implied. Image credit: National Cancer Institute, image 4187, circa 2006. Public domain. Original image source.
Diet during antibiotics: a transplant study puts the hospital menu under scrutiny
A clinic on wheels brings a survival signal—and a harder question about addiction care